|
| | SR0217 | | LRB100 11539 MST 22100 r |
|
|
1 | | SENATE RESOLUTION
|
2 | | WHEREAS, Lymphedema is swelling that occurs in the arms and |
3 | | legs of an individual, often
caused by the removal of, or |
4 | | damage to, lymph nodes as part of a cancer treatment or other
|
5 | | infection; and
|
6 | | WHEREAS, The factors that increase the risk of lymphedema |
7 | | include cancer treatment, age,
excess weight or obesity, or |
8 | | rheumatoid or psoriatic arthritis; and
|
9 | | WHEREAS, Undiagnosed lymphedema can lead to serious |
10 | | complications, such as bacterial
infections of the skin and |
11 | | lymph vessels or lymphangiosarcoma, which is a rare form of |
12 | | soft tissue
cancer that results from severe cases of the |
13 | | disease; and
|
14 | | WHEREAS, Lymphedema cannot be cured, but the symptoms can |
15 | | be managed through a variety
of treatment options, such as |
16 | | exercise, massage, therapy, and compression garments; and
|
17 | | WHEREAS, The necessary compression garments and therapy |
18 | | treatment options can cost
between $200-$3,000 for a patient |
19 | | and are often not covered by insurance plans; and
|
20 | | WHEREAS, Lymphedema is not well-known and is often |